Hb normalisation and rapid correction of anaemia are avoided because of the increased risk of cardiovascular events and vascular access thrombosis, as demonstrated in large ESA trials, although results were not granular enough to identify the factors responsible for this (Table 2). Here, GSTM1 is linked to anemia.